<unk> utic regimens are based on platinum agents such as cisplatin, carboplatin, oxaliplatin, and satraplatin. Alternative regimens include paclitaxel, gemcitabine, or etoposide.<unk> utic regimens are adjusted based on individual characteristics and body surface. The regimen adjustment according to tumor evolution has  demonstrated longer survival rates, optimal symptom control, and higher quality of life.
Non small cell lung cancer chemotherapy
Squamous cell carcinoma of the lung chemotherapy
Non small cell lung cancer medical therapy
Lung cancer medical therapy
Non small cell lung cancer radiation therapy
Lung mass medical therapy
Squamous cell carcinoma of the lung medical therapy
Small cell carcinoma of the lung medical therapy